Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study

被引:13
作者
Basu, Ansu [1 ,2 ]
Agwu, Juliana Chizo [3 ,4 ]
Barlow, Nicola [5 ]
Lee, Brian [1 ]
机构
[1] Sandwell & West Birmingham NHS Trust, Diabet Endocrinol & Lipid Metab, Birmingham, W Midlands, England
[2] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Birmingham, W Midlands, England
[3] Sandwell & West Birmingham NHS Trust, Paediat, Birmingham, W Midlands, England
[4] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England
[5] Sandwell & West Birmingham NHS Trust, Black Country Pathol Serv, Birmingham, W Midlands, England
关键词
COVID-19; hypertension; general diabetes; epidemiology; MORTALITY; MEN;
D O I
10.1136/bmjopen-2020-047561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the impact of diabetes, hypertension and cardiovascular diseases on inpatient mortality from COVID-19, and its relationship to ethnicity and social deprivation. Design Retrospective, single-centre observational study Setting Birmingham, UK. Participants 907 hospitalised patients with laboratory-confirmed COVID-19 from a multi-ethnic community, admitted between 1 March 2020 and 31 May 2020. Main outcome measures The primary analysis was an evaluation of cardiovascular conditions and diabetes in relation to ethnicity and social deprivation, with the end-point of inpatient death or death within 30 days of discharge. A multivariable logistic regression model was used to calculate HRs while adjusting for confounders. Results 361/907 (39.8%) died in hospital or within 30 days of discharge. The presence of diabetes and hypertension together appears to confer the greatest mortality risk (OR 2.75; 95% CI 1.80 to 4.21; p<0.001) compared with either condition alone. Age >65 years (OR 3.32; 95% CI 2.15 to 5.11), male sex (OR 2.04; 95% CI 1.47 to 2.82), hypertension (OR 1.69; 95% CI 1.10 to 2.61) and cerebrovascular disease (OR 1.87; 95% CI 1.31 to 2.68) were independently associated with increased risk of death. The mortality risk did not differ between the quintiles of deprivation. High-sensitivity troponin I was the best predictor of mortality among biomarkers (OR 4.43; 95% CI 3.10 to 7.10). Angiotensin-receptor blockers (OR 0.57; 95% CI 0.33 to 0.96) and ACE inhibitors (OR 0.65; 95% CI 0.43 to 0.97) were not associated with adverse outcome. The Charlson Index of Comorbidity scores were significantly higher in non-survivors. Conclusions The combined prevalence of hypertension and diabetes appears to confer the greatest risk, where diabetes may have a modulating effect. Hypertension and cerebrovascular disease had a significant impact on inpatient mortality. Social deprivation and ethnicity did not have any effect once the patient was in hospital.
引用
收藏
页数:10
相关论文
共 30 条
[1]   Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study [J].
Barron, Emma ;
Bakhai, Chirag ;
Kar, Partha ;
Weaver, Andy ;
Bradley, Dominique ;
Ismail, Hassan ;
Knighton, Peter ;
Holman, Naomi ;
Khunti, Kamlesh ;
Sattar, Naveed ;
Wareham, Nicholas J. ;
Young, Bob ;
Valabhji, Jonathan .
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) :813-822
[2]   Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality [J].
Bonow, Robert O. ;
Fonarow, Gregg C. ;
O'Gara, Patrick T. ;
Yancy, Clyde W. .
JAMA CARDIOLOGY, 2020, 5 (07) :751-753
[3]  
Caussy C, 2020, LANCET DIABETES ENDO, V8, P562, DOI [10.1016/S2213-8587(20)30160-0, 10.1016/S2213-8587(20)30160-1]
[4]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]   Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study [J].
Cummings, Matthew J. ;
Baldwin, Matthew R. ;
Abrams, Darryl ;
Jacobson, Samuel D. ;
Meyer, Benjamin J. ;
Balough, Elizabeth M. ;
Aaron, Justin G. ;
Claassen, Jan ;
Rabbani, LeRoy E. ;
Hastie, Jonathan ;
Hochman, Beth R. ;
Salazar-Schicchi, John ;
Yip, Natalie H. ;
Brodie, Daniel ;
O'Donnell, Max R. .
LANCET, 2020, 395 (10239) :1763-1770
[6]   Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? [J].
Fang, Lei ;
Karakiulakis, George ;
Roth, Michael .
LANCET RESPIRATORY MEDICINE, 2020, 8 (04) :E21-E21
[7]   Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors [J].
Ferrario, CM ;
Jessup, J ;
Gallagher, PE ;
Averill, DB ;
Brosnihan, KB ;
Tallant, EA ;
Smith, RD ;
Chappell, MC .
KIDNEY INTERNATIONAL, 2005, 68 (05) :2189-2196
[8]   Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study [J].
Gao, Chao ;
Cai, Yue ;
Zhang, Kan ;
Zhou, Lei ;
Zhang, Yao ;
Zhang, Xijing ;
Li, Qi ;
Li, Weiqin ;
Yang, Shiming ;
Zhao, Xiaoyan ;
Zhao, Yuying ;
Wang, Hui ;
Liu, Yi ;
Yin, Zhiyong ;
Zhang, Ruining ;
Wang, Rutao ;
Yang, Ming ;
Hui, Chen ;
Wijns, William ;
McEvoy, J. William ;
Soliman, Osama ;
Onuma, Yoshinobu ;
Serruys, Patrick W. ;
Tao, Ling ;
Li, Fei .
EUROPEAN HEART JOURNAL, 2020, 41 (22) :2058-2066
[9]   Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study [J].
Goshua, George ;
Pine, Alexander B. ;
Meizlish, Matthew L. ;
Chang, C-Hong ;
Zhang, Hanming ;
Bahel, Parveen ;
Baluha, Audrey ;
Bar, Noffar ;
Bona, Robert D. ;
Burns, Adrienne J. ;
Dela Cruz, Charles S. ;
Dumont, Anne ;
Halene, Stephanie ;
Hwa, John ;
Koff, Jonathan ;
Menninger, Hope ;
Neparidze, Natalia ;
Price, Christina ;
Siner, Jonathan M. ;
Tormey, Christopher ;
Rinder, Henry M. ;
Chun, Hyung J. ;
Lee, Alfred, I .
LANCET HAEMATOLOGY, 2020, 7 (08) :E575-E582
[10]   Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [J].
Grasselli, Giacomo ;
Zangrillo, Alberto ;
Zanella, Alberto ;
Antonelli, Massimo ;
Cabrini, Luca ;
Castelli, Antonio ;
Cereda, Danilo ;
Coluccello, Antonio ;
Foti, Giuseppe ;
Fumagalli, Roberto ;
Iotti, Giorgio ;
Latronico, Nicola ;
Lorini, Luca ;
Merler, Stefano ;
Natalini, Giuseppe ;
Piatti, Alessandra ;
Ranieri, Marco Vito ;
Scandroglio, Anna Mara ;
Storti, Enrico ;
Cecconi, Maurizio ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1574-1581